HIGHLIGHTS
- who: Caroline Schmitt-Koopmann from the Service of Addiction Medicine, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland have published the paper: Switzerland`s Dependence on a Diamorphine Monopoly, in the Journal: (JOURNAL)
- what: Switzerland has so far been lucky in that it has not suffered a shortage of diamorphine; nevertheless, the unstable supply was evidenced recently by reports in Switzerland and Germany.
- how: Structure of the Article This article describes Switzerland`s dependence on a diamorphine monopoly.
SUMMARY
Indeed, the Swiss Agency for Therapeutic Products (Swissmedic) approved . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.